- Healthcare
- Social
- Retail
- Main
You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
|
OMB
APPROVAL
|
|
|
OMB Number:
Expires:
|
3235-0060
March 31, 2006
|
|
Estimated
average burden
hours
per
response …28.0
|
|
UNITED
STATES
SECURITIESANDEXCHANGECOMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
Date
of Report (Date of earliest event reported)
|
May
11, 2009
|
|
APPLIED
NANOTECH HOLDINGS, INC.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
TEXAS
|
1-11602
|
76-0273345
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
3006
Longhorn Boulevard, Suite 107, Austin, Texas
|
78758
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
(512)
339 - 5020
|
|
Registrant’s
telephone number, including area
code
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e
-4(c))
Item
5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
On May
11, 2009, the Board of Directors accepted the resignation of Thomas F. Bijou as
Chief Executive Officer of the Company for personal reasons. Mr. Bijou also
resigned as a member of the Board of Directors and Chairman of the Board of the
Company. Mr. Bijou’s resignation is not in connection with any disagreement with
the Company on any matter relating to our operations, policies, or practices.
Dr. Robert Ronstadt, a Director since 2003, was named Chairman of the Board of
Directors, and Douglas P. Baker, Chief Financial Officer of the Company was
named Chief Executive Officer. Mr. Bijou will remain available for transition
assistance for a period of up to three months. Additional information on Dr.
Ronstadt and Mr. Baker is available in the Company’s 10-K for 2008 available at
www.sec.gov, or
the Company’s website at www.appliednanotech.net.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits:
99.1
Press release dated May 15, 2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Nano-Proprietary,
Inc.
|
|
|
By:/s/ Douglas P.
Baker
|
|
|
Date:
May 15, 2009
|
Douglas
P. Baker
Chief
Financial Officer
|